ATIC and cancer: In contrast to these agents, which directly inhibit ATIC’s enzymatic activity, Cpd14 is a peptide-based ATIC inhibitor that disrupts the enzyme’s homodimerization and thus indirectly impairs its activity and the proliferation of certain cancer cell types [27, 28].